AbbVie ends 11-year Calico partnership focused on aging research
FierceBiotech - 12-Nov-2025AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
Join the club for FREE to access the whole archive and other member benefits.
Track where the serious money is being invested in the longevity industry.
AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
Funding accelerates Stentrode’s clinical progress and hands-free device control for paralysis
Click on resource name for more details.
26-Jun-2026
The global event empowering everyone to live longer, better – now (London, UK)
24-Jun-2026
Aging affects everyone. But what if we could age better and could prevent disease before it starts? (Dublin, Ireland)
Longevity Roadmap Podcast- Karl Pfleger discusses longevity’s evolving science and investment scene
16-Oct-2025
The Alliance for Longevity Initiatives event gathering investors in longevity startups (Los Angeles, CA, USA)
Scotch McClure shares the latest from Maxwell Biosciences
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science